203 related articles for article (PubMed ID: 1363510)
1. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
[TBL] [Abstract][Full Text] [Related]
2. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
3. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
4. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
6. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT-29 human colonic carcinoma cells and on the reversal of the differentiated phenotype.
Tanaka Y; Bush KK; Eguchi T; Ikekawa N; Taguchi T; Kobayashi Y; Higgins PJ
Arch Biochem Biophys; 1990 Feb; 276(2):415-23. PubMed ID: 2306105
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of NaF-induced differentiation of HL-60 cells.
Kawase T; Oguro A; Orikasa M; Burns DM
J Bone Miner Res; 1996 Nov; 11(11):1676-87. PubMed ID: 8915775
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 enhances cytosolic free calcium in HL-60 cells.
Barnea E; Levy R; Zimlichman R; Shany S
Exp Hematol; 1990 Dec; 18(11):1147-51. PubMed ID: 2226676
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3.
Studzinski GP; Bhandal AK; Brelvi ZS
Cancer Res; 1985 Aug; 45(8):3898-905. PubMed ID: 3860289
[TBL] [Abstract][Full Text] [Related]
12. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414
[TBL] [Abstract][Full Text] [Related]
13. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
15. The involvement of calcium ions in the effect of 1,25-dihydroxyvitamin D3 on HL-60 cells.
Levy R; Nathan I; Barnea E; Chaimovitz C; Shany S
Exp Hematol; 1988 May; 16(4):290-4. PubMed ID: 3129299
[TBL] [Abstract][Full Text] [Related]
16. Effects of sex steroids on cell differentiation and interleukin-1 beta production in the human promyelocytic leukemia cell line HL-60.
Mori H; Sawairi M; Itoh N; Hanabayashi T; Tamaya T
J Reprod Med; 1992 Oct; 37(10):871-8. PubMed ID: 1479572
[TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
18. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
19. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3.
Honda A; Nakashima N; Shida Y; Mori Y; Nagata A; Ishizuka S
Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]